KRAS and neoplasm: Still, the existing data suggest that KRAS mutations in cancer cells can alter the behavior of fibroblasts, which in turn affect both the cancer cells and the microenvironment through extracellular matrix (ECM) changes and growth factor signaling, contributing to tumor progression [6,14].